NVCN
Neovasc Inc.
Set alert
30.03 0.00 0.00%
29.43 Day range 30.07
52-week range unavailable
- Open
- 29.59
- Prev close
- 30.03
- Mkt cap
- 83.59M
- Vol
- 1
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 29.43
- High
- 30.07
- Forward P/E
- -2.91
- Beta
- 0.00
- Short ratio
- 0.94
- Inst. own
- 7.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 11, 2023
- 50-d avg
- 29.31
- 200-d avg
- 15.47
- 1y target
- 24.00
Key statistics
- Market cap
- 83.59M
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- -2.91
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 2.94
- EPS (TTM)
- -15.07
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 2.76M
- Short % of float
- 1.05%
- 50-day average
- 29.31
- 200-day average
- 15.47
Analyst view
Consensus: hold
Hold
Price target (mean) 24.00 -20.1% downside
Now 30.03
- Target (low)
- 20.00
- Target (mean)
- 24.00
- Target (high)
- 28.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
May 11, 2023
Expected May 11, 2023. Consensus EPS estimate -2.71.
Financials — quick view
NVCN Revenue — quarterly 1.45M
NVCN Net income — quarterly -13.84M
NVCN EPS — quarterly -5.04
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 11, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Mar 31, 2023 | Dec 1, 2022 | -1.93 | — | — | — |
| Nov 10, 2022 | Sep 1, 2022 | -2.82 | — | — | — |
| Aug 11, 2022 | Jun 1, 2022 | -1.25 | — | — | — |
| May 12, 2022 | Mar 1, 2022 | -1.25 | — | — | — |
| Mar 10, 2022 | Dec 1, 2021 | -2.50 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2020 | SVB Leerink | main | — | Outperform |
| Nov 25, 2020 | H.C. Wainwright | reit | — | Buy |
| Nov 25, 2020 | Canaccord Genuity | main | — | Buy |
| Nov 25, 2020 | H.C. Wainwright | init | — | Buy |
| Nov 25, 2020 | Leerink Swann | main | Outperform | Outperform |
| Nov 25, 2020 | Canaccord Genuity | main | Buy | Buy |
About Neovasc Inc.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Canada
- Website
- neovasc.com
News
- Shockwave Medical, Inc. Completes Acquisition of Neovasc
- Shockwave Medical Completes Acquisition of Neovasc
- Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
- Neovasc Shareholders Approve Acquisition by Shockwave Medical
- A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold
- Neovasc Announces German Reimbursement Renewal
- Mergers and Acquisitions in 2023 Off To A Strong Start
- Shockwave Medical To Buy Neovasc: Details (NVCN)
- Shockwave Medical to Acquire Neovasc
- Neovasc (NVCN) is on the Move, Here's Why the Trend Could be Sustainable
Your note
Sign in to keep a note on NVCN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Becker (Lisa Ann McFadde) | Senior Officer of Issuer | Exercise of rights | Aug 17, 2022 | 2,451 |
| Clark, Christopher John | Senior Officer of Issuer | Exercise of rights | Jun 21, 2022 | 49,095 |
| Colen (Fredericus A) | Senior Officer of Issuer | Exercise of rights | Jun 21, 2022 | 224,154 |
| Gallagher (Sarah Marie Hodgson) | Senior Officer of Issuer | Exercise of rights | Aug 17, 2022 | 1,458 |
| Geyer (Paul) | 10% Security Holder of Issuer | Acquisition or disposition in the public market | Nov 17, 2022 | 18,335 |
| Janzen (Doug) | Director of Issuer | Acquisition or disposition in the public market | Aug 18, 2022 | 38,779 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Natixis | 1.84% | 49,778 | 1.49M | Dec 30, 2022 |
| U.S. Capital Wealth Advisors, LLC | 0.69% | 18,780 | 563.96K | Dec 30, 2022 |
| Magnetar Financial LLC | 0.58% | 15,804 | 474.59K | Dec 30, 2022 |
| Choreo, LLC | 0.46% | 12,440 | 373.57K | Dec 30, 2022 |
| Morgan Stanley | 0.13% | 3,635 | 109.16K | Dec 30, 2022 |
| Bank of America Corporation | 0.10% | 2,701 | 81.11K | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.03% | 854 | 25.64K | Nov 29, 2022 |